About this trial
It will be a randomized clinical trial with a sample size of 66. A convenient sampling technique will be used to recruit the CABG phase II patients for the study. Then, they will be divided into three groups by block randomization. Weight-bearing Liuzijue Qigong will be given as a baseline treatment to all groups. In group A, patients will engage in multimodal circuit training while simultaneously viewing the nature scenes through VR in a clinical setting, in group B, patients will be given multimodal circuit training in a clinical setting while in group C, patients will be given multimodal circuit training through telerehabilitation. The dyspnea 12 Questionnaire will be used for measuring dyspnea, Cooper's 12-minute test will be used to assess cardiorespiratory fitness, echocardiography will be used to assess Left ventricular ejection fraction, EQ-5D-5L will be used to assess quality of life, and Pittsburgh Sleep Quality Index (PSQI) will be used to assess the quality of sleep. Data will be entered and analyzed through SPSS version 21.
Eligibility criteria
Qualifiers
Patients who underwent CABG surgery will be recruited after twelve weeks
Both male and female
Age 30-60 years old
LVEF of < 40%
Disqualifiers
Patient with recurrent history of CABG
Had a non-cardiac surgical procedure ≤2 months prior to recruitment
Unstable angina, uncontrolled hypertension (blood pressure >180/100 mmHg), a pacemaker or atrial fibrillation, documented peak orifice area valve stenosis, symptomatic peripheral arterial disease that limits exercise capacity.
Documented chronic obstructive pulmonary disease (FEV1 <60% and FVC <60%)
Trial design
Treatments tested in this trial
- multimodal circuit training while viewing nature scenes through VR in a clinical setting
- multimodal circuit training in a real-world clinical setting
- multimodal circuit training through telerehabilitation